These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. New contributions from basic science to understanding the effects of monoamine oxidase inhibiting antidepressants. Murphy DL; Garrick NA; Aulakh CS; Cohen RM J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):37-43. PubMed ID: 6735994 [TBL] [Abstract][Full Text] [Related]
6. Studies of selective and reversible monoamine oxidase inhibitors. Mann JJ; Aarons SF; Frances AJ; Brown RD J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):62-6. PubMed ID: 6429130 [TBL] [Abstract][Full Text] [Related]
7. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge]. Volz HP; Gleiter CH; Möller HJ Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342 [TBL] [Abstract][Full Text] [Related]
8. Differential response patterns to MAO inhibitors and tricyclics. Nies A J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487 [TBL] [Abstract][Full Text] [Related]
9. New perspectives on long-standing issues: the monoamine oxidase inhibitors. Robinson DS Psychopharmacol Bull; 1986; 22(1):12-5. PubMed ID: 3726057 [No Abstract] [Full Text] [Related]
10. The new generation of selective monoamine oxidase-inhibitors: biochemical, pharmacological and clinical perspectives. Riederer P; Laux G; Beckmann H; Saletu B; Waldmeier P; Fritze J; DaPrada M; Möller HJ; Schmauss M; Przuntek H Pharmacopsychiatry; 1988 Nov; 21(6):283-4. PubMed ID: 3244753 [No Abstract] [Full Text] [Related]
11. Psychodynamic aspects in the use of monoamine oxidase inhibitor antidepressants. Roskos SR; Takahashi T Bull Menninger Clin; 1981 Mar; 45(2):143-8. PubMed ID: 7260455 [No Abstract] [Full Text] [Related]
12. MAO inhibitors in chronic pain and depression. Raskin DE J Clin Psychiatry; 1982 Mar; 43(3):122. PubMed ID: 7073869 [No Abstract] [Full Text] [Related]
13. MAO inhibitors. new biochemical and clinical findings. Psychopharmacol Bull; 1981 Jul; 17(3):154-61. PubMed ID: 7291464 [No Abstract] [Full Text] [Related]
14. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression]. Nolen WA Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774 [TBL] [Abstract][Full Text] [Related]
15. [New selective monoamine oxidase inhibitors in the treatment of depressive disorders]. Psychiatr Prax; 1989 Aug; 16 Suppl 1():1-50. PubMed ID: 2587672 [No Abstract] [Full Text] [Related]
16. Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide. Nair NP; Ahmed SK; Kin NM J Psychiatry Neurosci; 1993 Nov; 18(5):214-25. PubMed ID: 7905288 [TBL] [Abstract][Full Text] [Related]
18. MAO inhibition as antidepressive mechanism reevaluated. A controlled study with tranylcypromine isomers. Beckmann H; Moises HW Mod Probl Pharmacopsychiatry; 1983; 19():211-4. PubMed ID: 6865965 [No Abstract] [Full Text] [Related]
19. An open trial of MAO inhibitors in bulimia. Stewart JW; Walsh BT; Wright L; Roose SP; Glassman AH J Clin Psychiatry; 1984 May; 45(5):217-9. PubMed ID: 6373746 [TBL] [Abstract][Full Text] [Related]
20. Discussion on the monoamine oxidase inhibitors. Schiele BC Psychopharmacol Bull; 1986; 22(1):16-8. PubMed ID: 3726062 [No Abstract] [Full Text] [Related] [Next] [New Search]